236 related articles for article (PubMed ID: 12950435)
1. Neuroanatomical circuits modulating fear and anxiety behaviors.
Charney DS
Acta Psychiatr Scand Suppl; 2003; (417):38-50. PubMed ID: 12950435
[TBL] [Abstract][Full Text] [Related]
2. The neurobiology of social anxiety disorder: the relevance of fear and anxiety.
Marcin MS; Nemeroff CB
Acta Psychiatr Scand Suppl; 2003; (417):51-64. PubMed ID: 12950436
[TBL] [Abstract][Full Text] [Related]
3. Do anxiety and depression have a common pathophysiological mechanism?
Boyer P
Acta Psychiatr Scand Suppl; 2000; (406):24-9. PubMed ID: 11131467
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics.
Mathew SJ; Price RB; Charney DS
Am J Med Genet C Semin Med Genet; 2008 May; 148C(2):89-98. PubMed ID: 18412102
[TBL] [Abstract][Full Text] [Related]
5. The human dimension: how the prefrontal cortex modulates the subcortical fear response.
Berkowitz RL; Coplan JD; Reddy DP; Gorman JM
Rev Neurosci; 2007; 18(3-4):191-207. PubMed ID: 18019606
[TBL] [Abstract][Full Text] [Related]
6. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
Ressler KJ; Nemeroff CB
Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
[TBL] [Abstract][Full Text] [Related]
7. Forebrain glutamatergic, but not GABAergic, neurons mediate anxiogenic effects of the glucocorticoid receptor.
Hartmann J; Dedic N; Pöhlmann ML; Häusl A; Karst H; Engelhardt C; Westerholz S; Wagner KV; Labermaier C; Hoeijmakers L; Kertokarijo M; Chen A; Joëls M; Deussing JM; Schmidt MV
Mol Psychiatry; 2017 Mar; 22(3):466-475. PubMed ID: 27240530
[TBL] [Abstract][Full Text] [Related]
8. A view on noradrenergic, hypothalamic-pituitary-adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: the reduced growth hormone response to clonidine.
Coplan JD; Pine DS; Papp LA; Gorman JM
Psychopharmacol Bull; 1997; 33(2):193-204. PubMed ID: 9230631
[No Abstract] [Full Text] [Related]
9. Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor.
Bhatnagar S; Sun LM; Raber J; Maren S; Julius D; Dallman MF
Physiol Behav; 2004 Jun; 81(4):545-55. PubMed ID: 15178147
[TBL] [Abstract][Full Text] [Related]
10. Association of fear auras with mood and anxiety disorders after temporal lobectomy.
Kohler CG; Carran MA; Bilker W; O'Connor MJ; Sperling MR
Epilepsia; 2001 May; 42(5):674-81. PubMed ID: 11380577
[TBL] [Abstract][Full Text] [Related]
11. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
Ströhle A
Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
[TBL] [Abstract][Full Text] [Related]
12. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia.
Etkin A; Wager TD
Am J Psychiatry; 2007 Oct; 164(10):1476-88. PubMed ID: 17898336
[TBL] [Abstract][Full Text] [Related]
13. The neurobiological basis of mixed depression-anxiety states.
Gulley LR; Nemeroff CB
J Clin Psychiatry; 1993 Jan; 54 Suppl():16-9. PubMed ID: 8093884
[TBL] [Abstract][Full Text] [Related]
14. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias.
Sullivan GM; Coplan JD; Kent JM; Gorman JM
Biol Psychiatry; 1999 Nov; 46(9):1205-18. PubMed ID: 10560026
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone suppression test in patients with panic attacks.
Bridges M; Yeragani VK; Rainey JM; Pohl R
Biol Psychiatry; 1986 Jul; 21(8-9):853-5. PubMed ID: 3730467
[No Abstract] [Full Text] [Related]
16. Interactions of anxiolytic and antidepressant drugs with hormones of the hypothalamic-pituitary-adrenal axis.
File SE
Pharmacol Ther; 1990; 46(3):357-75. PubMed ID: 1971443
[TBL] [Abstract][Full Text] [Related]
17. The dexamethasone suppression test in panic disorder and major depressive episodes.
Faludi G; Kaskó M; Perényi A; Arató M; Frecska E
Biol Psychiatry; 1986 Sep; 21(11):1008-14. PubMed ID: 3741916
[TBL] [Abstract][Full Text] [Related]
18. Chronic activation of NPFFR2 stimulates the stress-related depressive behaviors through HPA axis modulation.
Lin YT; Liu TY; Yang CY; Yu YL; Chen TC; Day YJ; Chang CC; Huang GJ; Chen JC
Psychoneuroendocrinology; 2016 Sep; 71():73-85. PubMed ID: 27243477
[TBL] [Abstract][Full Text] [Related]
19. Psychoneuroendocrinology of anxiety disorders.
Sullivan GM; Coplan JD; Gorman JM
Psychiatr Clin North Am; 1998 Jun; 21(2):397-412. PubMed ID: 9670233
[TBL] [Abstract][Full Text] [Related]
20. [Neuroimaging and pathology in anxiety disorders, especially stress-induced fear circuitry disorders].
Shioiri T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Jun; 30(3):135-9. PubMed ID: 20666145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
